by Sam Eskandari | Apr 24, 2020 | News
VANCOUVER, British Columbia, April 24th, 2020 – Veritas Pharma Inc. (CSE: VRT; OTC: VRTHF; and Frankfurt: 2VP) (“Veritas” or the “Company”) wishes to announce that it has appointed Lorne Mark Roseborough as Chairman of the Board. The Company also wishes to...
by Sam Eskandari | Feb 19, 2020 | News
VANCOUVER, British Columbia, February 19, 2019 — Veritas Pharma Inc. (CSE: VRT; OTC: VRTHF; and Frankfurt: 2VP) (“Veritas” or the “Company”) wishes to announces that it has entered into a debt settlement agreement with its Interim CEO and CFO, Mr. Peter...
by Sam Eskandari | Feb 13, 2020 | News
VANCOUVER, British Columbia, February 13, 2020 – Veritas Pharma Inc. (CSE: VRT; OTC: VRTHF; and Frankfurt: 2VP) (“Veritas” or the “Company”) announces its preliminary human study results of its lead cannabis treatment for acute pain, CTL-X, as well as, the...
by Sam Eskandari | Nov 26, 2019 | News
VANCOUVER, British Columbia, November 26, 2019 — Veritas Pharma Inc. (CSE: VRT; OTC: VRTHF; and Frankfurt: 2VP) (“Veritas” or the “Company”) has commenced legal proceedings in the Supreme Court of British Columbia against Luigi Franciosi, David Alexander, Linda...
by Sam Eskandari | Aug 28, 2019 | News
VANCOUVER, British Columbia, August 28, 2019 — Veritas Pharma Inc. (CSE: VRT; OTC: VRTHF; and Frankfurt: 2VP) (“Veritas” or the “Company”). Further to the Company’s news release of November 14, 2018, the sale of the Company’s 100% interest in Sechelt Organic...
